Aptullahoglu, E.; Nakjang, S.; Wallis, J.P.; Marr, H.; Marshall, S.; Willmore, E.; Lunec, J.
RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic Leukemia. Biomedicines 2024, 12, 1388.
https://doi.org/10.3390/biomedicines12071388
AMA Style
Aptullahoglu E, Nakjang S, Wallis JP, Marr H, Marshall S, Willmore E, Lunec J.
RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic Leukemia. Biomedicines. 2024; 12(7):1388.
https://doi.org/10.3390/biomedicines12071388
Chicago/Turabian Style
Aptullahoglu, Erhan, Sirintra Nakjang, Jonathan P. Wallis, Helen Marr, Scott Marshall, Elaine Willmore, and John Lunec.
2024. "RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic Leukemia" Biomedicines 12, no. 7: 1388.
https://doi.org/10.3390/biomedicines12071388
APA Style
Aptullahoglu, E., Nakjang, S., Wallis, J. P., Marr, H., Marshall, S., Willmore, E., & Lunec, J.
(2024). RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic Leukemia. Biomedicines, 12(7), 1388.
https://doi.org/10.3390/biomedicines12071388
